Abstract
Human papillomavirus (HPV) testing is increasingly recommended for cervical cancer screening. To evaluate the potential large-scale implementation of HPV testing in Morocco, we conducted a pilot study to assess its acceptability and feasibility in four provinces. This study involved 999 women aged 30 or 40 years. Face-to-face interviews were conducted, and HPV testing was performed via the GeneXpert system. Of the 1097 women invited, 91.1% were involved. Most participants (62.9%) were from urban areas, with age groups distributed between 30 s (46.0%) and 40 s (54.0%). The majority of the samples were received without issues affecting HPV testing. The mean time from sample collection to test results was 7.5 ± 6.1 days. On the GeneXpert workstation, 1.1% of the samples yielded invalid results. Among the remaining 972 samples, HPV DNA was detected in 4.8% of the samples, with HPV 16 being the most common type (27.7%). Among the HPV-positive patients, 21.3% refused colposcopy. Among those who underwent colposcopy, abnormal findings (51.4%) included TAG I, TAG II, and suspected invasive cancer. Biopsies revealed normal findings in 47.4%, CIN1 (21.1%), CIN2 (10.5%), CIN3 (15.8%), and carcinoma in situ (5.2%) patients. All patients were managed in accordance with the World Health Organization (WHO) guidelines for comprehensive cervical cancer control (WHO, 2014). HPV testing via the GeneXpert platform may be a reliable and user-friendly tool for the early detection of cervical lesions, with the potential to reduce the incidence and mortality of cervical cancer in Morocco.
Similar content being viewed by others
Abbreviations
- HPV:
-
Human papillomavirus
- TAG:
-
Transformation area grade (Grade de la zone de transformation)
- CIN:
-
Cervical intraepithelial neoplasia
- LEEP:
-
Loop electrosurgical excision procedure
- WHO:
-
World Health Organization
- HC:
-
Health Center
- VIA:
-
Visual inspection with acetic acid
Acknowledgements
The authors would like to thank all the health centers’ medical staff and all the recruited women for their valuable support. Special thanks to the Cepehid Company in France for their kind collaboration and for providing XpertHPV kits with collection media. Finally, we express our gratitude to the Fondation Lalla Salma - Prévention et Traitement des Cancers for its full funding of this study.
Funding
The study was funded entirely by the Fondation Lalla Salma-Prévention et Traitement des Cancers. The Xpert HPV tests and sample transport media were made available to the Lalla Salma Foundation by Cepheid. The GenXpert systems were loaned by Cepheid for the duration of the study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
The study protocol was approved by the Ethics Committee of Medical Research at the Faculty of Medicine and Pharmacy in Rabat (Ref 31 − 22). Written informed consent was obtained from all women prior to enrolment. Participation was voluntary, and confidentiality of data was ensured throughout the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Bahra, N., Chami, Y., Bekkali, R. et al. Feasibility and acceptability of HPV testing using GeneXpert for cervical cancer screening in Morocco. Sci Rep (2026). https://doi.org/10.1038/s41598-026-46200-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-46200-x
